|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.787
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.719
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.594
|
Zebrafish Rat Worm |
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.541
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.522
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.469
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.385
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.349
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.308
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.251
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.244
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.239
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.227
|
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.217
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.216
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.210
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.205
|
|
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.204
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.201
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.198
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.188
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.175
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.171
|
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.167
|
|
|
|
cellular potassium ion transport
|
GO:0071804 |
43 |
0.162
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.158
|
|
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
50 |
0.156
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.156
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.155
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
54 |
0.146
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.146
|
Zebrafish Mouse Rat |
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.144
|
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
4 |
0.144
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.144
|
|
|
|
granzyme mediated apoptotic signaling pathway
|
GO:0008626 |
1 |
0.140
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.139
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.130
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.127
|
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
28 |
0.126
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.126
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.123
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.122
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.120
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.119
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.119
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.119
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.119
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.116
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.116
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.110
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.110
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.106
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.103
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.103
|
|
|
|
potassium ion transmembrane transport
|
GO:0071805 |
43 |
0.101
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.099
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.099
|
Zebrafish Mouse Rat |
|
|
organic acid transport
|
GO:0015849 |
101 |
0.098
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.097
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.096
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.095
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.095
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.094
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.094
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.093
|
|
|
|
ventricular cardiac myofibril assembly
|
GO:0055005 |
3 |
0.093
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.092
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.091
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.091
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.089
|
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.088
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.087
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.086
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.086
|
|
|
|
diacylglycerol biosynthetic process
|
GO:0006651 |
2 |
0.086
|
|
|
|
spinal cord oligodendrocyte cell fate specification
|
GO:0021530 |
3 |
0.084
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.084
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.081
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.080
|
|
|
|
positive regulation of vasoconstriction
|
GO:0045907 |
4 |
0.079
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.078
|
|
|
|
terpenoid metabolic process
|
GO:0006721 |
25 |
0.077
|
|
|
|
triglyceride homeostasis
|
GO:0070328 |
15 |
0.077
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.077
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.077
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.076
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.074
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.073
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.073
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.072
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.072
|
|
|
|
sensory perception of pain
|
GO:0019233 |
47 |
0.072
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.071
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.070
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.070
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.070
|
|
|
|
spleen development
|
GO:0048536 |
39 |
0.069
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.067
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.067
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.066
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.066
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.066
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.065
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.065
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.065
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.064
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.064
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.064
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.063
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.062
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.062
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.061
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.061
|
|
|
|
potassium ion transport
|
GO:0006813 |
52 |
0.061
|
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
43 |
0.060
|
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.059
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.059
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.059
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.057
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.057
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.057
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.057
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.057
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.057
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.056
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.056
|
|
|
|
negative regulation of execution phase of apoptosis
|
GO:1900118 |
4 |
0.056
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.055
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.055
|
Rat |
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.055
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.055
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.054
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.053
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.053
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.053
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.053
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.053
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.052
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.052
|
|
|
|
regulation of cation channel activity
|
GO:2001257 |
22 |
0.052
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.051
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.051
|
|
|
|
regulation of nitrogen cycle metabolic process
|
GO:1903314 |
1 |
0.051
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.051
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.051
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.050
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.050
|
|
|
|
positive regulation of peptide secretion
|
GO:0002793 |
33 |
0.049
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.049
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.048
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.048
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.048
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.048
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.048
|
|
|
|
sarcomere organization
|
GO:0045214 |
24 |
0.048
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.047
|
|
|
|
regulation of phosphatidylcholine biosynthetic process
|
GO:2001245 |
2 |
0.047
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.047
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.047
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.047
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
43 |
0.047
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.046
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.046
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.046
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.045
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.045
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.045
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.045
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.045
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.045
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.045
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.045
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.044
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.044
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.044
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.044
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.044
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.043
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.043
|
|
|
|
regulation of sterol transport
|
GO:0032371 |
17 |
0.043
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.043
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.043
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.043
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.043
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.043
|
|
|
|
response to alkaloid
|
GO:0043279 |
34 |
0.042
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.042
|
|
|
|
neutrophil mediated killing of gram positive bacterium
|
GO:0070946 |
2 |
0.042
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.042
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.041
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.041
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
44 |
0.041
|
|
|
|
regulation of cardioblast differentiation
|
GO:0051890 |
3 |
0.041
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.041
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.041
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.040
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.040
|
|
|
|
diacylglycerol metabolic process
|
GO:0046339 |
6 |
0.040
|
|
|
|
potassium ion homeostasis
|
GO:0055075 |
4 |
0.040
|
|
|
|
positive regulation of voltage gated calcium channel activity
|
GO:1901387 |
2 |
0.040
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.040
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.039
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.039
|
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.039
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.039
|
|
|
|
ventricular cardiac muscle cell differentiation
|
GO:0055012 |
17 |
0.038
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.038
|
|
|
|
regulation of angiotensin levels in blood
|
GO:0002002 |
4 |
0.038
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.038
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.038
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.038
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.038
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.037
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.037
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.037
|
|
|
|
cellular carbohydrate catabolic process
|
GO:0044275 |
15 |
0.037
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.037
|
|
|
|
positive regulation of glycolytic process
|
GO:0045821 |
4 |
0.037
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.037
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.037
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.037
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.037
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.036
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.036
|
|
|
|
carbohydrate catabolic process
|
GO:0016052 |
32 |
0.036
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.036
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.036
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.036
|
|
|
|
regulation of renin secretion into blood stream
|
GO:1900133 |
4 |
0.036
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.035
|
|
|
|
regulation of systemic arterial blood pressure by circulatory renin angiotensin
|
GO:0001991 |
13 |
0.035
|
|
|
|
body fluid secretion
|
GO:0007589 |
53 |
0.035
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.035
|
Rat |
|
|
rhythmic process
|
GO:0048511 |
174 |
0.035
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.035
|
|
|
|
lung cell differentiation
|
GO:0060479 |
30 |
0.035
|
|
|
|
regulation of inward rectifier potassium channel activity
|
GO:1901979 |
1 |
0.035
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.035
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.035
|
|
|
|
positive regulation of insulin secretion
|
GO:0032024 |
26 |
0.035
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.034
|
|
|
|
fatty acid oxidation
|
GO:0019395 |
28 |
0.034
|
|
|
|
lung secretory cell differentiation
|
GO:0061140 |
13 |
0.034
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.034
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.034
|
|
|
|
monoamine transport
|
GO:0015844 |
33 |
0.034
|
|
|
|
adipose tissue development
|
GO:0060612 |
25 |
0.034
|
|
|
|
purinergic nucleotide receptor signaling pathway
|
GO:0035590 |
3 |
0.034
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.034
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.034
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.033
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.033
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.033
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.033
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.033
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.033
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.033
|
|
|
|
regulation of chloride transport
|
GO:2001225 |
2 |
0.033
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.032
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.032
|
|
|
|
killing by host of symbiont cells
|
GO:0051873 |
11 |
0.032
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.032
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.032
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.031
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.031
|
|
|
|
negative regulation of sterol transport
|
GO:0032372 |
4 |
0.031
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.031
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.031
|
|
|
|
regulation of circadian sleep wake cycle sleep
|
GO:0045187 |
3 |
0.031
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.031
|
|
|
|
regulation of angiotensin metabolic process
|
GO:0060177 |
4 |
0.030
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.030
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.030
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.030
|
|
|
|
lipid storage
|
GO:0019915 |
36 |
0.030
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.030
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.030
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.030
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.030
|
|
|
|
histamine transport
|
GO:0051608 |
2 |
0.030
|
|
|
|
neutrophil mediated immunity
|
GO:0002446 |
19 |
0.030
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.029
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.029
|
|
|
|
regulation of mitochondrial membrane potential
|
GO:0051881 |
17 |
0.029
|
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
48 |
0.029
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.029
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.029
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.029
|
|
|
|
response to bile acid
|
GO:1903412 |
1 |
0.029
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.029
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.029
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.029
|
|
|
|
oligodendrocyte development
|
GO:0014003 |
20 |
0.029
|
|
|
|
t cell extravasation
|
GO:0072683 |
4 |
0.028
|
|
|
|
columnar cuboidal epithelial cell maturation
|
GO:0002069 |
4 |
0.028
|
|
|
|
long chain fatty acid import
|
GO:0044539 |
2 |
0.028
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.028
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.028
|
|
|
|
regulation of fatty acid oxidation
|
GO:0046320 |
10 |
0.028
|
|
|
|
regulation of action potential
|
GO:0098900 |
4 |
0.028
|
|
|
|
positive regulation of fatty acid oxidation
|
GO:0046321 |
4 |
0.028
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
71 |
0.028
|
|
|
|
regulation of phospholipid biosynthetic process
|
GO:0071071 |
3 |
0.028
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.028
|
|
|
|
regulation of calcium ion transmembrane transport
|
GO:1903169 |
20 |
0.028
|
|
|
|
fat cell proliferation
|
GO:0070341 |
4 |
0.028
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.027
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.027
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.027
|
|
|
|
vasodilation
|
GO:0042311 |
28 |
0.027
|
|
|
|
modification of morphology or physiology of other organism involved in symbiotic interaction
|
GO:0051817 |
16 |
0.027
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.027
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.027
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.027
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.027
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.027
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.027
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.027
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.027
|
|
|
|
retinoic acid metabolic process
|
GO:0042573 |
12 |
0.027
|
|
|
|
modification of morphology or physiology of other organism
|
GO:0035821 |
18 |
0.026
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.026
|
|
|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
0.026
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.026
|
|
|
|
positive regulation of cell fate commitment
|
GO:0010455 |
8 |
0.026
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.026
|
|
|
|
positive regulation of peptide hormone secretion
|
GO:0090277 |
31 |
0.026
|
|
|
|
b cell activation involved in immune response
|
GO:0002312 |
50 |
0.026
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.026
|
|
|
|
histamine uptake
|
GO:0051615 |
1 |
0.026
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.026
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.025
|
|
|
|
regulation of cardiac muscle contraction
|
GO:0055117 |
21 |
0.025
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.025
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.025
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.025
|
|
|
|
regulation of transcription from rna polymerase ii promoter involved in spinal cord motor neuron fate specification
|
GO:0021912 |
3 |
0.025
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.025
|
|
|
|
regulation of cholesterol transport
|
GO:0032374 |
17 |
0.025
|
|
|
|
positive regulation of apoptotic process involved in morphogenesis
|
GO:1902339 |
4 |
0.025
|
|
|
|
positive regulation of ion transmembrane transporter activity
|
GO:0032414 |
15 |
0.025
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.025
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.024
|
|
|
|
lipoprotein metabolic process
|
GO:0042157 |
43 |
0.024
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.024
|
|
|
|
regulation of glycogen catabolic process
|
GO:0005981 |
2 |
0.024
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.024
|
|
|
|
cytokine production involved in immune response
|
GO:0002367 |
34 |
0.024
|
|
|
|
white fat cell differentiation
|
GO:0050872 |
15 |
0.024
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.024
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.024
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.024
|
|
|
|
spinal cord motor neuron differentiation
|
GO:0021522 |
35 |
0.024
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.024
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.024
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.024
|
|
|
|
regulation of g protein activated inward rectifier potassium channel activity
|
GO:1900128 |
1 |
0.024
|
|
|
|
polysaccharide metabolic process
|
GO:0005976 |
39 |
0.024
|
|
|
|
cell cell signaling involved in mammary gland development
|
GO:0060764 |
2 |
0.024
|
|
|
|
positive regulation of glial cell differentiation
|
GO:0045687 |
21 |
0.024
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.024
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.023
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.023
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.023
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.023
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.023
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.023
|
|
|
|
positive regulation of blood circulation
|
GO:1903524 |
22 |
0.023
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.023
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.023
|
|
|
|
chondrocyte hypertrophy
|
GO:0003415 |
4 |
0.023
|
|
|
|
regulation of calcium ion transmembrane transporter activity
|
GO:1901019 |
20 |
0.023
|
|
|
|
long chain fatty acid transport
|
GO:0015909 |
15 |
0.023
|
|
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
40 |
0.022
|
|
|
|
regulation of vitamin d biosynthetic process
|
GO:0060556 |
1 |
0.022
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.022
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.022
|
|
|
|
regulation of glutamate metabolic process
|
GO:2000211 |
1 |
0.022
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.022
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.022
|
|
|
|
glycerophospholipid biosynthetic process
|
GO:0046474 |
32 |
0.022
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.022
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.022
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.022
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.022
|
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.022
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.022
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.022
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.022
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.022
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.022
|
|
|
|
negative regulation of blood pressure
|
GO:0045776 |
22 |
0.022
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.022
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.021
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.021
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.021
|
|
|
|
pyruvate metabolic process
|
GO:0006090 |
28 |
0.021
|
|
|
|
ventral midline development
|
GO:0007418 |
4 |
0.021
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.021
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.021
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.021
|
|
|
|
intestinal absorption
|
GO:0050892 |
13 |
0.021
|
|
|
|
disruption of cells of other organism involved in symbiotic interaction
|
GO:0051818 |
13 |
0.021
|
|
|
|
regulation of ventricular cardiac muscle cell membrane depolarization
|
GO:0060373 |
2 |
0.021
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.021
|
|
|
|
ammonia assimilation cycle
|
GO:0019676 |
2 |
0.021
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.021
|
|
|
|
lipid oxidation
|
GO:0034440 |
29 |
0.021
|
|
|
|
ventricular cardiac muscle cell development
|
GO:0055015 |
11 |
0.021
|
|
|
|
polyol metabolic process
|
GO:0019751 |
26 |
0.021
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.021
|
|
|
|
cholesterol efflux
|
GO:0033344 |
24 |
0.021
|
|
|
|
regulation of immunological synapse formation
|
GO:2000520 |
2 |
0.021
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.020
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.020
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.020
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.020
|
|
|
|
positive regulation of ion transmembrane transport
|
GO:0034767 |
24 |
0.020
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.020
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.020
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.020
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.020
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.020
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.020
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.020
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.020
|
|
|
|
acylglycerol homeostasis
|
GO:0055090 |
16 |
0.020
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.020
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.020
|
|
|
|
isoprenoid metabolic process
|
GO:0006720 |
29 |
0.020
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.020
|
Worm |
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.020
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.020
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.020
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.020
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.019
|
|
|
|
satellite cell activation involved in skeletal muscle regeneration
|
GO:0014901 |
3 |
0.019
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.019
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.019
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.019
|
|
|
|
hexose transport
|
GO:0008645 |
56 |
0.019
|
|
|
|
forebrain neuron fate commitment
|
GO:0021877 |
13 |
0.019
|
|
|
|
vitamin d biosynthetic process
|
GO:0042368 |
3 |
0.019
|
|
|
|
bronchiole development
|
GO:0060435 |
3 |
0.019
|
|
|
|
reflex
|
GO:0060004 |
22 |
0.019
|
|
|
|
negative regulation of cholesterol transport
|
GO:0032375 |
4 |
0.019
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.019
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.019
|
|
|
|
modification by host of symbiont morphology or physiology
|
GO:0051851 |
12 |
0.019
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.019
|
|
|
|
bronchiole morphogenesis
|
GO:0060436 |
1 |
0.019
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.019
|
|
|
|
relaxation of muscle
|
GO:0090075 |
18 |
0.018
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.018
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.018
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.018
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.018
|
|
|
|
his purkinje system cell differentiation
|
GO:0060932 |
2 |
0.018
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.018
|
|
|
|
regulation of ammonia assimilation cycle
|
GO:2001248 |
1 |
0.018
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.018
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.018
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.018
|
|
|
|
negative regulation of cholesterol efflux
|
GO:0090370 |
4 |
0.018
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.018
|
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
41 |
0.018
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.018
|
|
|
|
regulation of fat cell proliferation
|
GO:0070344 |
4 |
0.018
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.018
|
|
|
|
spinal cord oligodendrocyte cell differentiation
|
GO:0021529 |
3 |
0.018
|
|
|
|
glucan metabolic process
|
GO:0044042 |
32 |
0.018
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.018
|
|
|
|
adenylate cyclase activating g protein coupled receptor signaling pathway
|
GO:0007189 |
30 |
0.018
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.018
|
|
|
|
positive regulation of cyclic nucleotide biosynthetic process
|
GO:0030804 |
24 |
0.018
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.018
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.018
|
|
|
|
phospholipid biosynthetic process
|
GO:0008654 |
36 |
0.017
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.017
|
|
|
|
regulation of norepinephrine secretion
|
GO:0014061 |
2 |
0.017
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.017
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.017
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.017
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.017
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.017
|
|
|
|
central nervous system myelination
|
GO:0022010 |
12 |
0.017
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.017
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.017
|
|
|
|
norepinephrine secretion
|
GO:0048243 |
2 |
0.017
|
|
|
|
regulation of fatty acid biosynthetic process
|
GO:0042304 |
12 |
0.017
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.017
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.017
|
|
